NCT06375044
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06375044
Title Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jiangsu Simcere Pharmaceutical Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer institution NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai,The Tisch Cancer Institute RECRUITING New York New York 10029 United States Details
Beijing Chaoyang Hospital Capital Medical University RECRUITING Beijing Beijing Municipality 100000 China Details
Sun Yat-sen University Cancer Center RECRUITING Guangzhou Guangdong 510000 China Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan 450000 China Details
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences RECRUITING Tianjin Tianjin Municipality 300000 China Details
The First Affiliated Hospital Zhejiang University School of Medicine RECRUITING Hanzhou Zhejiang 310000 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field